Open company graph database — free web & API
Login

SANWA KAGAKU KENKYUSHO CO., LTD.

株式会社三和化学研究所
Ticker
—
Listed market
—
Country
Japan
Employees (non-consolidated)
—
Related companies
34
§01

Basic information

BASIC
Head office
35 Higashi-Gaihocho, Higashi-ku, Nagoya, Aichi Prefecture
Chief executive
Shusaku Isono
Capital
211,088,000 JPY (2 100 millionJPY)
Employees (non-consolidated)
Employees (consolidated)
Start date
End date
§02

Websites

1 DOMAINS
§03

Business

4
Research and development of pharmaceuticalsResearch and development of diagnostic drugsManufacturing and sale of pharmaceuticalsContract manufacturing of pharmaceuticals
§04

Related companies

34 COMPANIES
Company name Group Parent Subsidiary Customer Supplier Alliance Bank Shareholder
S.D. Logi Corporation
Group
S Care Mate
Group
Shangyao Suzuken Huazhong (Shanghai) Pharmaceutical Co., Ltd.
Group
Sanki Medihart LLC
Group
Kyuyaku Service LLC
Group
Suzuken Joynas Co., Ltd.
Group
Suzuken Business Associate Co., Ltd.
Group
SHOYAKU CO.,LTD.
Group
Astis Corporation
Group
Collabo Square Inc.
Group
S.D. Collaborate Inc.
Group
Farmaize Holdings Inc.
Group
Galenos Corporation
Group
Silver Mate Co., Ltd.
Group
Central Transport Co., Ltd.
Group
Esmile Corporation
Group
Suzuken Iwate Co., Ltd.
Group
Unismile Corporation
Group
Medicare Collaboration Inc.
Group
Sanki Wellbe Co., Ltd.
Group
PSC Corporation
Group
Sankei Corporation
Group
EP Pharma Line
Group
Welby Healthcare Solutions Inc.
Group
P.J.D. Network Co., Ltd.
Group
Embrace Corporation
Group
KuraMed Corporation
Group
Nakano Pharmaceuticals Co., Ltd.
Group
J.I.T. Co., Ltd.
Group
Suzuken Okinawa Pharmaceuticals Co., Ltd.
Group
Net Hospital Co., Ltd.
Group
Poksannaise Corporation
Group
株式会社ライフサポート
Group
Suzuken Investment Co., Ltd.
Shareholder
Names without a link are companies not yet registered in OpenBizGraph
§05

Network

NETWORK
Drag to move · click to open
§06

History

38 EVENTS

Established "Mitsuwa Chemical Research Institute Co., Ltd." in Naka-ku, Nagoya. Kenzo Suzuki was appointed President.Sources

Launched the circulatory disorder improver "Carnaclin Tablets".Sources

Started production and sale of "Sanken Tea". Initially named "Sanken Tea".Sources

Opened a factory in Uto City, Kumamoto Prefecture. Launched the liver extract product "Adelavin No. 9".Sources

Completed the new headquarters building in Higashi-ku, Nagoya.Sources

The life science film "Medicine and Humans" received the Minister of Science and Technology Award.Sources

Launched the lipid metabolism and peripheral circulation improver "Perisic Capsule".Sources

Established the Kenzo Suzuki Memorial "Medical Science Applied Research Foundation".Sources

Opened a factory in Hobetsu Town, Yufutsu District, Hokkaido. The raw material factory began operation and started production of Carnaclin raw materials.Sources

Opened Mie Research Park in Kitasei Town, Ise District, Mie Prefecture. Opened Fukushima Factory in Aizuwakamatsu City, Fukushima Prefecture.Sources

Launched the sustained-release loop diuretic "Diaart Tablets".Sources

Launched the liquid thickened fluid food "Sante A".Sources

Launched the blood glucose self-monitoring device "GluTest E" and its dedicated sensor "Tromelin".Sources

Implemented CI to improve corporate image.Sources

Launched the transdermal cardiac treatment drug "Baserolator Tape" and the oral B-cell chronic hepatitis treatment drug "Cerocion Capsule 10".Sources

Launched the hyperkalemia improver "Argamite Gel". The Fukushima factory obtained ISO9002 certification.Sources

Rename Fukushima Factory to FUKUSHIMA Kōen.Sources

Establish a contact center.Sources

Launch water-soluble dietary fiber "Pine Fiber." Open website "Diabetes NikoNiko School." Release blood glucose self-monitoring device "GluTest Neo." Celebrate 50th anniversary with a memorial lecture featuring Dr. Ryoji Yanoi.Sources

Inherit the carbonic anhydrase inhibitor "Diamox."Sources

Release blood collection device "Gentlet" and dedicated needle "Gentlet Needle."Sources

Release postprandial hyperglycemia improvement drug "Seiburu Tablet."Sources

Sign contract with overseas pharmaceutical manufacturer for sales of "Carnaclin Tablet" and release blood glucose self-monitoring device "GluTest Neo Super."Sources

Release blood glucose self-monitoring device "GluTest Every." Sign license agreement for diabetes drug "SK-0403."Sources

OSDrC® building completed at Mie Research Park. Sign license agreement for hyperuricemia and gout drug "FYX-051."Sources

Implement 2.0 billion yen share capital increase. Capital becomes 2.11088 billion yen. Obtain "Next-Generation Development Support Promotion Act" certification mark (Kurumin) from Ministry of Health, Labour and Welfare.Sources

Release thick liquid food "JuiciO Mini." Receive Mond Selection Gold Award.Sources

Release type 2 diabetes treatment drug "Swinie Tablet."Sources

Celebrate 60th anniversary. Release blood glucose self-monitoring device "GluTest Neo Alpha." Release hyperuricemia treatment drug "Urealdeck Tablet."Sources

Production technology research building completed at FUKUSHIMA Kōen.Sources

Release postprandial hyperglycemia improvement drug "Seiburu OD Tablet."Sources

Release blood glucose self-monitoring device "GluTest Eye."Sources

Release disposable needle "Aipitt Mini." Release type 2 diabetes treatment drug "Metana Combination Tablet." Release physiological intestinal function improvement and high ammonia blood treatment gel "Lagnus NF Oral Gel."Sources

Release glucose analysis device "GluTest Mint II." Release sustained erythrocyte stimulating factor formulation "Darvepoetin Alpha BS Injection."Sources

Release blood glucose self-monitoring device "GluTest Aqua" and dedicated sensor "GluTest Blue Sensor." Release long-acting soluble insulin analog formulation "Insulin Glargine BS Injection Kit [FFP]."Sources

Release treatment drug for secondary hyperparathyroidism "Upasita Intravenous Dialysis Syringe."Sources

The blood collection device "Soflet" and the dedicated needle "Soflet Needle" are now available.Sources

Celebrating the 70th anniversary of the company's founding.Sources

§07

News

0 ARTICLES

There is no news.

§08

Public records

GOV
National Tax Agency basic information5180001016824
Source: National Tax Agency Corporate Number Publication Site, basic three itemsSources
Trade name
株式会社三和化学研究所
Trade name (kana)
サンワカガクケンキュウジョ
Name in English
Corporation type
301
Address
〒461-0017 愛知県名古屋市東区東外堀町35番地
Postal code
4610017
Prefecture code
23
City code
102
Address outside Japan
Prefecture in English
City in English
Address outside Japan in English
Corporate number assignment date
2015-10-05
Update date
2020-04-06
Change date
2015-10-05
Registry closure date
Reason for registry closure
Successor corporate number
Details of the change
Latest record
1
Excluded from search
0
Processing type
01
Correction type
1
Trade name image ID
Address image ID
Sequence number
3612700
METI gBizINFO5180001016824
Source: gBizINFO (Ministry of Economy, Trade and Industry)Sources
Corporate number
5180001016824
Trade name
株式会社三和化学研究所
Trade name (kana)
サンワカガクケンキュウジョ
Trade name (alphabet)
Registry closure date
Reason for registry closure
Registered address
愛知県名古屋市東区東外堀町35番地
Postal code
4610017
Prefecture
愛知県
Prefecture code
23
City or district
名古屋市東区
City code
102
Street address
東外堀町35番地
Organisation type
301
Processing type
01
Correction type
1
Status
Representative
Capital
Employees
836
Employees (male)
547
Employees (female)
278
Business summary
医薬品、診断薬の研究開発と製造販売、医薬品の受託生産
Website URL
http://www.skk-net.com/
Year founded
Business category
E:製造業
Date established
Unified government qualification - grade
Unified government qualification - business items
Update date
2020-04-06
Key information
5180001016824
§09

Sources & updates

SOURCES
↑